- B2C
- B2B
- Early StageStartup in initial stages
DNAsimple Funding
$625K
22 rounds
DNAsimple is active in the following markets / industries: biotechnology, health care, Researchers and Science. The company has secured funding across 2 rounds and is valued at $625K. Their most recent funding was raised on February 16, 2016.
Investors of DNAsimple
Y combinator created a new model for funding early stage startups
Rounds
S
Healthtech accelerator partnered deeply with leading providers and payers
Rounds
S
